Literature DB >> 21979247

Mutant enrichment with 3'-modified oligonucleotides a practical PCR method for detecting trace mutant DNAs.

Seung-Tae Lee1, Ji-Youn Kim, Min-Jung Kown, Sun Wook Kim, Jae Hoon Chung, Myung-Ju Ahn, Young Lyun Oh, Jong-Won Kim, Chang-Seok Ki.   

Abstract

Many clinical situations necessitate highly sensitive and reliable molecular assays; however, the achievement of such assays remains a challenge due to the inherent limitations of molecular testing methods. Here, we describe a simple and inexpensive enrichment technique that we call mutant enrichment with 3'-modified oligonucleotides (MEMO). The method is based on the use of a 3'-modified oligonucleotide primer that blocks extension of the normal allele but enables extension of the mutated allele. The performance of the technique was evaluated with respect to its ability to detect common cancer mutations in the EGFR, KRAS, BRAF, TP53, JAK2, and NPM1 genes. We achieved sensitivities of 10(-2) to 10(-6) using downstream Sanger sequencing, depending on the concentrations and thermodynamics of the primers. MEMO may be applicable to the quantitative real-time PCR platform and other downstream assays. This technique may be practically applicable to various medical situations.
Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979247      PMCID: PMC3194055          DOI: 10.1016/j.jmoldx.2011.07.003

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  31 in total

1.  Thermodynamic, counterion, and hydration effects for the incorporation of locked nucleic acid nucleotides into DNA duplexes.

Authors:  Harleen Kaur; Amit Arora; Jesper Wengel; Souvik Maiti
Journal:  Biochemistry       Date:  2006-06-13       Impact factor: 3.162

2.  A novel blocker-PCR method for detection of rare mutant alleles in the presence of an excess amount of normal DNA.

Authors:  T Seyama; T Ito; T Hayashi; T Mizuno; N Nakamura; M Akiyama
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

3.  Influencing factors of dsDNA dye (high-resolution) melting curves and improved genotype call based on thermodynamic considerations.

Authors:  Ekkehard Schütz; Nicolas von Ahsen
Journal:  Anal Biochem       Date:  2008-11-07       Impact factor: 3.365

4.  Detection of tumor mutations in the presence of excess amounts of normal DNA.

Authors:  Xiyuan Sun; K Hung; L Wu; D Sidransky; Baochuan Guo
Journal:  Nat Biotechnol       Date:  2002-02       Impact factor: 54.908

5.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).

Authors:  C R Newton; A Graham; L E Heptinstall; S J Powell; C Summers; N Kalsheker; J C Smith; A F Markham
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

6.  Single base pair mutation analysis by PNA directed PCR clamping.

Authors:  H Orum; P E Nielsen; M Egholm; R H Berg; O Buchardt; C Stanley
Journal:  Nucleic Acids Res       Date:  1993-11-25       Impact factor: 16.971

7.  EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance.

Authors:  Shi-Xu Jiang; Kazuya Yamashita; Michiko Yamamoto; Chun-Ji Piao; Atsuko Umezawa; Makoto Saegusa; Tsutomu Yoshida; Masato Katagiri; Noriyuki Masuda; Kazushige Hayakawa; Isao Okayasu
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

Review 8.  PCR-based methods for the enrichment of minority alleles and mutations.

Authors:  Coren A Milbury; Jin Li; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2009-02-06       Impact factor: 8.327

9.  Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide.

Authors:  P E Nielsen; M Egholm; R H Berg; O Buchardt
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

10.  Design of LNA probes that improve mismatch discrimination.

Authors:  Yong You; Bernardo G Moreira; Mark A Behlke; Richard Owczarzy
Journal:  Nucleic Acids Res       Date:  2006-05-02       Impact factor: 16.971

View more
  14 in total

1.  BRAF V600E mutation is a useful marker for differentiating Rathke's cleft cyst with squamous metaplasia from papillary craniopharyngioma.

Authors:  Jang-Hee Kim; Werner Paulus; Stephanie Heim
Journal:  J Neurooncol       Date:  2015-03-28       Impact factor: 4.130

2.  Mutant Enrichment with 3'-Modified Oligonucleotides (MEMO)-Quantitative PCR for Detection of NPM1 Mutations in Acute Myeloid Leukemia.

Authors:  Sang-Yong Shin; Chang-Seok Ki; Hee-Jin Kim; Jong-Won Kim; Sun-Hee Kim; Seung-Tae Lee
Journal:  J Clin Lab Anal       Date:  2014-11-10       Impact factor: 2.352

3.  Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area.

Authors:  Hye Jeong Kim; Hyeong Kyu Park; Dong Won Byun; Kyoil Suh; Myung Hi Yoo; Yong-Ki Min; Sun Wook Kim; Jae Hoon Chung
Journal:  Eur J Nutr       Date:  2017-03-03       Impact factor: 5.614

4.  Identification of a rare 3 bp BRAF gene deletion in a thyroid nodule by mutant enrichment with 3'-modified oligonucleotides polymerase chain reaction.

Authors:  Mi-Ae Jang; Seung-Tae Lee; Young Lyun Oh; Sun Wook Kim; Jae Hoon Chung; Chang-Seok Ki; Jong-Won Kim
Journal:  Ann Lab Med       Date:  2012-04-18       Impact factor: 3.464

5.  BRAF V600E and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone lymphoma cases.

Authors:  Sang-Yong Shin; Seung-Tae Lee; Hee-Jin Kim; Chang-Seok Ki; Chul Won Jung; Jong-Won Kim; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2015-02-12       Impact factor: 3.464

6.  Evaluation of the Anyplex BRAF V600E real-time detection assay using dual-priming oligonucleotide technology in fine-needle aspirates of thyroid nodules.

Authors:  Rihwa Choi; Kyung Sun Park; Jong Won Kim; Chang Seok Ki
Journal:  Ann Lab Med       Date:  2015-11       Impact factor: 3.464

7.  Peptide nucleic acid clamp polymerase chain reaction reveals a deletion mutation of the BRAF gene in papillary thyroid carcinoma: A case report.

Authors:  Yong-Wha Lee
Journal:  Exp Ther Med       Date:  2013-10-08       Impact factor: 2.447

8.  Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas.

Authors:  Sang-Yong Shin; Seung-Tae Lee; Hyun-Young Kim; Chang-Hun Park; Hee-Jin Kim; Jong-Won Kim; Seok Jin Kim; Won Seog Kim; Sun-Hee Kim
Journal:  Blood Res       Date:  2016-09-23

9.  Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia.

Authors:  W Jang; J-H Yoon; J Park; G D Lee; J Kim; A Kwon; H Choi; K Han; C H Nahm; H-J Kim; W-S Min; M Kim; Y Kim
Journal:  Blood Cancer J       Date:  2016-01-15       Impact factor: 11.037

10.  Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques.

Authors:  Tae Hyuk Kim; Dae Joon Jeong; Soo Yeon Hahn; Jung Hee Shin; Young Lyun Oh; Chang-Seok Ki; Jong-Won Kim; Ju Young Jang; Yoon Young Cho; Jae Hoon Chung; Sun Wook Kim
Journal:  Cancer Med       Date:  2016-01-18       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.